These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

760 related items for PubMed ID: 28780422

  • 1. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
    Singanallur NB, Pacheco JM, Arzt J, Stenfeldt C, Fosgate GT, Rodriguez L, Vosloo W.
    Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
    [Abstract] [Full Text] [Related]

  • 2. Protective effects of high-potency FMDV O1 Manisa monovalent vaccine in cattle challenged with FMDV O/SKR/2010 at 7 or 4 days post vaccination.
    Horsington J, Perez CB, Maradei E, Novo SG, Gonzales JL, Singanallur NB, Bonastre P, Vosloo W.
    Vaccine; 2017 Sep 12; 35(38):5179-5185. PubMed ID: 28789849
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Early protection in sheep against intratypic heterologous challenge with serotype O foot-and-mouth disease virus using high-potency, emergency vaccine.
    Horsington J, Zhang Z, Bittner H, Hole K, Singanallur NB, Alexandersen S, Vosloo W.
    Vaccine; 2015 Jan 09; 33(3):422-9. PubMed ID: 25483241
    [Abstract] [Full Text] [Related]

  • 5. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
    Moraes MP, Segundo FD, Dias CC, Pena L, Grubman MJ.
    Vaccine; 2011 Nov 28; 29(51):9431-40. PubMed ID: 22027486
    [Abstract] [Full Text] [Related]

  • 6. A Malaysia 97 monovalent foot-and-mouth disease vaccine (>6PD50/dose) protects pigs against challenge with a variant FMDV A SEA-97 lineage virus, 4 and 7 days post vaccination.
    Nagendrakumar SB, Hong NT, Geoffrey FT, Jacqueline MM, Andrew D, Michelle G, Van Phuc K, Ngon QV, Phuong le TT, Phuc NN, Hanh TX, Van Hung V, Quynhanh le T, Tan TM, Long NT, Wilna V.
    Vaccine; 2015 Aug 26; 33(36):4513-9. PubMed ID: 26192355
    [Abstract] [Full Text] [Related]

  • 7. Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine.
    Fernandez-Sainz I, Medina GN, Ramirez-Medina E, Koster MJ, Grubman MJ, de Los Santos T.
    Virology; 2017 Feb 26; 502():123-132. PubMed ID: 28039799
    [Abstract] [Full Text] [Related]

  • 8. Protection in sheep against heterologous challenge with serotype Asia-1 foot-and-mouth disease virus using high potency vaccine.
    Horsington J, Nfon C, Gonzales JL, Singanallur N, Bittner H, Vosloo W.
    Vaccine; 2018 Oct 01; 36(41):6095-6102. PubMed ID: 30195485
    [Abstract] [Full Text] [Related]

  • 9. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
    Barrera J, Schutta C, Pisano M, Grubman MJ, Brake DA, Miller T, Kamicker BJ, Olutunmbi F, Ettyreddy D, Brough DE, Butman BT, Neilan JG.
    Vaccine; 2018 Feb 14; 36(8):1078-1084. PubMed ID: 29358056
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of a high potency O1 Manisa foot-and-mouth disease vaccine in cattle against heterologous challenge with a field virus from the O/ME-SA/Ind-2001 lineage collected in North Africa.
    Fishbourne E, Ludi AB, Wilsden G, Hamblin P, Statham B, Bin-Tarif A, Brocchi E, Grazioli S, Dekker A, Eblé P, King DP.
    Vaccine; 2017 May 09; 35(20):2761-2765. PubMed ID: 28396208
    [Abstract] [Full Text] [Related]

  • 11. Effect of FMD vaccine antigen payload on protection, sub-clinical infection and persistence following needle challenge in sheep.
    Madhanmohan M, Nagendrakumar SB, Narasu ML, Srinivasan VA.
    Comp Immunol Microbiol Infect Dis; 2010 Dec 09; 33(6):e7-13. PubMed ID: 19896714
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of cross-protection between O1 Manisa and O1 Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O1 Manisa antigen.
    Nagendrakumar SB, Srinivasan VA, Madhanmohan M, Yuvaraj S, Parida S, Di Nardo A, Horsington J, Paton DJ.
    Vaccine; 2011 Feb 24; 29(10):1906-12. PubMed ID: 21236232
    [Abstract] [Full Text] [Related]

  • 13. Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge.
    Schutta C, Barrera J, Pisano M, Zsak L, Grubman MJ, Mayr GA, Moraes MP, Kamicker BJ, Brake DA, Ettyreddy D, Brough DE, Butman BT, Neilan JG.
    Vaccine; 2016 Jun 08; 34(27):3214-3220. PubMed ID: 26707216
    [Abstract] [Full Text] [Related]

  • 14. A Vaccine Based on the A/ASIA/G-VII Lineage of Foot-and-Mouth Disease Virus Offers Low Levels of Protection against Circulating Viruses from the A/ASIA/Iran-05 lineage.
    Singanallur NB, Eblé PL, Ludi AB, Statham B, Bin-Tarif A, King DP, Dekker A, Vosloo W.
    Viruses; 2022 Jan 06; 14(1):. PubMed ID: 35062300
    [Abstract] [Full Text] [Related]

  • 15. Clinical protection, sub-clinical infection and persistence following vaccination with extinction payloads of O1 Manisa Foot-and-Mouth Disease monovalent vaccine and challenge in goats and comparison with sheep.
    Madhanmohan M, Nagendrakumar SB, Kumar R, Anilkumar J, Manikumar K, Yuvaraj S, Srinivasan VA.
    Res Vet Sci; 2012 Oct 06; 93(2):1050-9. PubMed ID: 22079173
    [Abstract] [Full Text] [Related]

  • 16. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle.
    Cox SJ, Voyce C, Parida S, Reid SM, Hamblin PA, Hutchings G, Paton DJ, Barnett PV.
    Vaccine; 2006 Apr 12; 24(16):3184-90. PubMed ID: 16488060
    [Abstract] [Full Text] [Related]

  • 17. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs.
    Eblé PL, de Bruin MG, Bouma A, van Hemert-Kluitenberg F, Dekker A.
    Vaccine; 2006 Feb 27; 24(9):1274-81. PubMed ID: 16289709
    [Abstract] [Full Text] [Related]

  • 18. Cross-protective efficacy of the O1 Manisa + O 3039 bivalent vaccine and the O 3039 monovalent vaccine against heterologous challenge with FMDV O/Jincheon/SKR/2014 in pig.
    Kim T, Hong JK, Oem JK, Lee KN, Lee HS, Kim YJ, Ryoo S, Ko YJ, Park JH, Choi J, Lee SH, Jo HJ, Lee MH, Kim B, Kim J.
    Vaccine; 2019 Mar 14; 37(12):1702-1709. PubMed ID: 30712811
    [Abstract] [Full Text] [Related]

  • 19. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
    Pan L, Zhang Z, Lv J, Zhou P, Hu W, Fang Y, Chen H, Liu X, Shao J, Zhao F, Ding Y, Lin T, Chang H, Zhang J, Zhang Y, Wang Y.
    Int J Nanomedicine; 2014 Mar 14; 9():5603-18. PubMed ID: 25506214
    [Abstract] [Full Text] [Related]

  • 20. The B-cell response to foot-and-mouth-disease virus in cattle following vaccination and live-virus challenge.
    Grant CFJ, Carr BV, Singanallur NB, Morris J, Gubbins S, Hudelet P, Ilott M, Charreyre C, Vosloo W, Charleston B.
    J Gen Virol; 2016 Sep 14; 97(9):2201-2209. PubMed ID: 27260141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.